Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

Daiichi Sankyo and AstraZeneca cheer EU milestone for cancer drug

19th Jan 2026 09:42

(Alliance News) - Daiichi Sanyko Co Ltd on Monday said EU regulators had validated an application for its breast cancer treatment, Enhertu with pertuzumab, jointly developed with AstraZeneca PLC. Read More

LONDON BROKER RATINGS: BofA cuts British Land; RBC raises Gym Group

16th Jan 2026 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: Stocks in green as US manufacturing surprises

15th Jan 2026 17:00

(Alliance News) - Stock prices in London closed higher on Thursday, after a surprise drop in US jobless claims. Read More

Hutchmed China hails lung cancer trial results published in Lancet

14th Jan 2026 12:06

(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet. Read More

LONDON MARKET MIDDAY: Miners lift FTSE 100 ahead of US PPI

14th Jan 2026 11:57

(Alliance News) - Stock prices in London were mixed at midday on Wednesday, as gains among miners lifted the FTSE 100. Read More

Polar Capital Global Healthcare Trust beats benchmark; demand "robust"

14th Jan 2026 10:10

(Alliance News) - Polar Capital Global Healthcare Trust PLC on Wednesday said demand for healthcare products remains robust as it outperformed its benchmark. Read More

UK will compete with US on growth, Peter Kyle to tell business chiefs

14th Jan 2026 06:35

(Alliance News) - UK Business Secretary Peter Kyle is set to tell the heads of top firms that he will "fight tooth and nail" to achieve US levels of economic growth. Read More

LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma

7th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: Next impresses as FTSE 100 rockets to fresh high

6th Jan 2026 17:04

(Alliance News) - Blue chips continued their strong start to the year on Tuesday with the FTSE 100 hitting a new record led by gains in retailer Next and drug stocks, GSK and AstraZeneca. Read More

AstraZeneca flags positive trial data for Saphnelo as SLE treatment

6th Jan 2026 09:47

(Alliance News) - AstraZeneca PLC on Tuesday said a Saphnelo self-administration Thlip-SC trial demonstrated statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity. Read More

Hutchmed savolitinib NDA for gastric cancer accepted in China

30th Dec 2025 11:21

(Alliance News) - Hutchmed China Ltd on Tuesday said Chinese regulators have accepted and granted priority review to its new drug application for savolitinib to treat certain patients with advanced gastric cancer, marking another regulatory step forward for the targeted therapy. Read More

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

24th Dec 2025 13:14

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought some life to proceedings. Read More

LONDON MARKET OPEN: FTSE mixed in shortened Christmas Eve trade

24th Dec 2025 09:17

(Alliance News) - Stock prices in London opened modestly lower on Wednesday, during a shortened trading session ahead of the Christmas holiday break. Read More

AstraZeneca says lung cancer trial fails to meet survival target

22nd Dec 2025 09:11

(Alliance News) - AstraZeneca PLC on Monday said a phase three trial in a potential treatment for a form of non-small cell lung cancer failed to meet a key aim, while its early breast cancer drug has been granted a breakthrough therapy designation in the US. Read More

LONDON BRIEFING: Harbour Energy makes USD3.2 billion US buy

22nd Dec 2025 07:52

(Alliance News) - Harbour Energy has struck a deal to deliver on a "long-standing ambition", while AstraZeneca reports a drug failed to meet its primary endpoint in a phase three trial, while another got breakthrough therapy designation in the US. Read More

Daiichi Sankyo, AstraZeneca apply for second EU approval for Datroway

18th Dec 2025 12:27

(Alliance News) - Daiichi Sankyo Co Ltd on Thursday said the EU has validated an application for Datroway as a first-line treatment for patients with metastatic triple negative breast cancer who are not candidates for immunotherapy. Read More

AstraZeneca's Saphnelo gets EU approval for self-administration

16th Dec 2025 09:53

(Alliance News) - AstraZeneca PLC on Tuesday said its drug Saphnelo, or anifrolumab, has been approved in the European Union as a new pre-filled pen for systemic lupus erythematosus. Read More

AstraZeneca and Daiichi Sankyo's enhertu gets US cancer approval

15th Dec 2025 20:46

(Alliance News) - AstraZeneca PLC on Monday said enhertu plus pertuzumab has been approved in the US as a first-line treatment of patients with HER2-positive metastatic breast cancer. Read More

Outgoing GSK CEO Emma Walmsley declares US best place to invest

11th Dec 2025 09:35

(Alliance News) - Outgoing GSK PLC Chief Executive Officer Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain's pharmaceutical sector, after a raft of drugs firms have scrapped or paused plans to invest in the UK. Read More

Hutchmed drugs stay on NRDL; Tazverik added to new insurance list

8th Dec 2025 11:15

(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer drugs has secured a place on the country's first-ever commercial insurance drug list. Read More

12345678910
FTSE 100 Latest
Value10,195.35
Change0.00